Literature DB >> 29175515

Innate immune control of alphavirus infection.

Kathryn S Carpentier1, Thomas E Morrison2.   

Abstract

Alphaviruses are important human pathogens that cause diseases ranging from acute and chronic polyarthralgia to encephalitis. Transmitted by mosquito vectors, alphaviruses have high potential for emergence and have initiated several recent epidemics. The innate immune response is critical for controlling the acute phase of alphavirus disease, and the induction of type I interferon (IFN) is essential in this response. In this review, we discuss our current understanding of innate host sensors that initiate antiviral responses following alphavirus infection, and the IFN-induced effector proteins that limit alphavirus replication and dissemination.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29175515      PMCID: PMC5835171          DOI: 10.1016/j.coviro.2017.11.006

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  12 in total

1.  Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses.

Authors:  Colleen B Jonsson; Xufeng Cao; Jasper Lee; Jon D Gabbard; Yong-Kyu Chu; Elizabeth A Fitzpatrick; Justin Julander; Dong-Hoon Chung; Jennifer Stabenow; Jennifer E Golden
Journal:  Antiviral Res       Date:  2019-04-07       Impact factor: 5.970

2.  TF protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner.

Authors:  K J Rogers; S Jones-Burrage; W Maury; S Mukhopadhyay
Journal:  Virology       Date:  2020-01-07       Impact factor: 3.616

3.  N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.

Authors:  Kothila Tharmarajah; Arun Everest-Dass; Jelena Vider; Xiang Liu; Joseph R Freitas; Helen Mostafavi; Jayaram Bettadapura; Mark von Itzstein; Nicholas P West; Adam Taylor; Suresh Mahalingam; Ali Zaid
Journal:  J Virol       Date:  2022-08-24       Impact factor: 6.549

4.  A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice.

Authors:  Julie M Fox; Ling Huang; Stephen Tahan; Laura A Powell; James E Crowe; David Wang; Michael S Diamond
Journal:  PLoS Pathog       Date:  2020-08-06       Impact factor: 6.823

5.  Phenotypic and Kinetic Changes of Myeloid Lineage Cells in Innate Response to Chikungunya Infection in Cynomolgus Macaques.

Authors:  Brandon J Beddingfield; Chie Sugimoto; Eryu Wang; Scott C Weaver; Kasi E Russell-Lodrigue; Stephanie Z Killeen; Marcelo J Kuroda; Chad J Roy
Journal:  Viral Immunol       Date:  2022-03-25       Impact factor: 2.175

6.  Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate.

Authors:  Natalie A Prow; Thiago D C Hirata; Bing Tang; Thibaut Larcher; Pamela Mukhopadhyay; Tiago Lubiana Alves; Thuy T Le; Joy Gardner; Yee Suan Poo; Eri Nakayama; Viviana P Lutzky; Helder I Nakaya; Andreas Suhrbier
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

Review 7.  Pathogenic Th1 responses in CHIKV-induced inflammation and their modulation upon Plasmodium parasites co-infection.

Authors:  Anthony Torres-Ruesta; Teck-Hui Teo; Yi-Hao Chan; Laurent Rénia; Lisa F P Ng
Journal:  Immunol Rev       Date:  2019-11-26       Impact factor: 12.988

8.  A Tale of 20 Alphaviruses; Inter-species Diversity and Conserved Interactions Between Viral Non-structural Protein 3 and Stress Granule Proteins.

Authors:  Gwen Nowee; Julian W Bakker; Corinne Geertsema; Vera I D Ros; Giel P Göertz; Jelke J Fros; Gorben P Pijlman
Journal:  Front Cell Dev Biol       Date:  2021-02-11

Review 9.  Disease Resolution in Chikungunya-What Decides the Outcome?

Authors:  Priyanshu Srivastava; Ankit Kumar; Abdul Hasan; Divya Mehta; Ramesh Kumar; Chetan Sharma; Sujatha Sunil
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

Review 10.  Self-amplifying RNA vaccines for infectious diseases.

Authors:  Kristie Bloom; Fiona van den Berg; Patrick Arbuthnot
Journal:  Gene Ther       Date:  2020-10-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.